|
Type 2 diabetes
Citations 311-320 of 450 total displayed.
|
Past content
(since Jan 2001):
|
- Basic Science Reports
Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 Diabetes
- J. William Phillips, Kurt G. Barringhaus, John M. Sanders, Zandong Yang, Meng Chen, Sean Hesselbacher, Ann C. Czarnik, Klaus Ley, Jerry Nadler, and Ian J. Sarembock
Circulation 2003;108:1994-1999; published online before print as doi:10.1161/01.CIR.0000092886.52404.50
[Abstract]
[Full text]
- Clinical Investigations and Reports
Tumor Necrosis Factor- Inhibits Insulin’s Stimulating Effect on Glucose Uptake and Endothelium-Dependent Vasodilation in Humans
- Christian Rask-Madsen, Helena Domínguez, Nikolaj Ihlemann, Thomas Hermann, Lars Køber, and Christian Torp-Pedersen
Circulation 2003;108:1815-1821; published online before print as doi:10.1161/01.CIR.0000091406.72832.11
[Abstract]
[Full text]
- Articles
Association of Insulin Resistance, Hyperleptinemia, and Impaired Nitric Oxide Release With In-Stent Restenosis in Patients Undergoing Coronary Stenting
- PierMarco Piatti, Carlo Di Mario, Lucilla D. Monti, Gabriele Fragasso, Fabio Sgura, Andrea Caumo, Emanuela Setola, Pietro Lucotti, Elena Galluccio, Cristina Ronchi, Anna Origgi, Ivana Zavaroni, Alberto Margonato, and Antonio Colombo
Circulation published October 6, 2003, doi:10.1161/01.CIR.0000095272.67948.17
[Abstract]
- Articles
Tumor Necrosis Factor- Inhibits Insulin's Stimulating Effect on Glucose Uptake and Endothelium-Dependent Vasodilation in Humans
- Christian Rask-Madsen, Helena Domínguez, Nikolaj Ihlemann, Thomas Hermann, Lars Køber, and Christian Torp-Pedersen
Circulation published October 6, 2003, doi:10.1161/01.CIR.0000091406.72832.11
[Abstract]
- Mini-Review: Expert Opinions
Epidemic Obesity and the Metabolic Syndrome
- Steven Haffner and Heinrich Taegtmeyer
Circulation 2003;108:1541-1545, doi:10.1161/01.CIR.0000088845.17586.EC
[Full text]
- Review: Clinical Cardiology: New Frontiers
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II
- Thomas F. Lüscher, Mark A. Creager, Joshua A. Beckman, and Francesco Cosentino
Circulation 2003;108:1655-1661, doi:10.1161/01.CIR.0000089189.70578.E2
[Full text]
- Articles
Rosiglitazone Reduces the Accelerated Neointima Formation After Arterial Injury in a Mouse Injury Model of Type 2 Diabetes
- J. William Phillips, Kurt G. Barringhaus, John M. Sanders, Zandong Yang, Meng Chen, Sean Hesselbacher, Ann C. Czarnik, Klaus Ley, Jerry Nadler, and Ian J. Sarembock
Circulation published September 29, 2003, doi:10.1161/01.CIR.0000092886.52404.50
[Abstract]
- Cardiology Patient Pages
C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke
- Paul M Ridker
Circulation 2003;108:e81-85e, doi:10.1161/01.CIR.0000093381.57779.67
[Full text]
- Review: Clinical Cardiology: New Frontiers
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
- Mark A. Creager, Thomas F. Lüscher, Francesco Cosentino, and Joshua A. Beckman
Circulation 2003;108:1527-1532, doi:10.1161/01.CIR.0000091257.27563.32
[Full text]
- Clinical Investigations and Reports
Bilateral Versus Unilateral Internal Mammary Revascularization in Patients With Diabetes
- Masahiro Endo, Yasuko Tomizawa, and Hiroshi Nishida
Circulation 2003;108:1343-1349; published online before print as doi:10.1161/01.CIR.0000085995.87982.6E
[Abstract]
[Full text]
|
|
